Eunyoung Lee

Eunyoung Lee

Auto-generated profile, based on publicly available information

Eunyoung Lee

Department of Medical Physiology, Chiba University, Graduate School of Medicine, Chiba 260-8670, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YMYujie Ma
Yujie Ma
ELEunyoung Lee
Eunyoung Lee
HYHayato Yoshikawa
Hayato Yoshikawa
TNTomoe Noda
Tomoe Noda
JMJunki Miyamoto
Junki Miyamoto
Takashi MikiTakashi Miki
Takashi Miki

Verified
Journal Article
Open access
PDF file
ELEunyoung Lee
Eunyoung Lee
EMEmily L. Miedzybrodzka
Emily L. Miedzybrodzka
XZXilin Zhang
Xilin Zhang
RHRyo Hatano
Ryo Hatano
JMJunki Miyamoto
Junki Miyamoto
Takashi MikiTakashi Miki
Takashi Miki
As glucose-dependent insulinotropic polypeptide (GIP) possesses pro-adipogenic action, the suppression of the GIP hypersecretion seen in obesity might represent a novel therapeutic approach to the treatment of obesity. However, the mechanism of GIP hypersecretion remains largely unknown. In the present study, we investigated GIP secretion in two mouse models of obesity: High-fat diet-induced obese (DIO) mice and leptin-deficient Lepob/ob mice. In DIO mice, plasma GIP was increased along with an increase in GIP mRNA expression in the lower small intestine. Despite the robust alteration in the gut microbiome in DIO mice, co-administration of maltose and the α-glucosidase inhibitor (α-GI) miglitol induced the microbiome-mediated suppression of GIP secretion. The plasma GIP levels of Lepob/ob mice were also elevated and were suppressed by fat transplantation. The GIP mRNA expression in fat tissue was not increased in Lepob/ob mice, while the expression of an interleukin-1 receptor antagonist (IL-1Ra) was increased. Fat transplantation suppressed the expression of IL-1Ra. The plasma IL-1Ra levels were positively correlated with the plasma GIP levels. Accordingly, although circulating GIP levels are increased in both DIO and Lepob/ob mice, the underlying mechanisms differ, and the anti-obesity actions of α-GIs and leptin sensitizers may be mediated partly by the suppression of GIP secretion.

Verified
Journal Article
Open access
PDF file
ELEunyoung Lee
Eunyoung Lee
XZXilin Zhang
Xilin Zhang
TNTomoe Noda
Tomoe Noda
JMJunki Miyamoto
Junki Miyamoto
IKIkuo Kimura
Ikuo Kimura
Takashi MikiTakashi Miki
Takashi Miki
Background: α-cyclodextrin (α-CD) is one of the dietary fibers that may have a beneficial effect on cholesterol and/or glucose metabolism, but its efficacy and mode of action remain unclear. Methods: In the present study, we examined the anti-hyperglycemic effect of α-CD after oral loading of glucose and liquid meal in mice. Results: Administration of 2 g/kg α-CD suppressed hyperglycemia after glucose loading, which was associated with increased glucagon-like peptide 1 (GLP-1) secretion and enhanced hepatic glucose sequestration. By contrast, 1 g/kg α-CD similarly suppressed hyperglycemia, but without increasing secretions of GLP-1 and insulin. Furthermore, oral α-CD administration disrupts lipid micelle formation through its inclusion of lecithin in the gut luminal fluid. Importantly, prior inclusion of α-CD with lecithin in vitro nullified the anti-hyperglycemic effect of α-CD in vivo, which was associated with increased intestinal mRNA expressions of SREBP2-target genes (Ldlr, Hmgcr, Pcsk9, and Srebp2). Conclusions: α-CD elicits its anti-hyperglycemic effect after glucose loading by inducing lecithin inclusion in the gut lumen and activating SREBP2, which is known to induce cholecystokinin secretion to suppress hepatic glucose production via a gut/brain/liver axis.

29 December 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YGYi Guan
Yi Guan
YYYang Yu
Yang Yu
MFMengdi Fu
Mengdi Fu
HXHongde Xu
Hongde Xu
ELEunyoung Lee
Eunyoung Lee
LCLiu Cao
Liu Cao
Diabetes and insulin resistance (IR) remain major global health challenges, underscoring the need for novel therapeutic strategies. Here, we identify an autophagy-independent role of circulating autophagy-related gene 7 (ATG7) in metabolic regulation. Circulating ATG7 enhances insulin sensitivity and glucose homeostasis by directly interacting with IRS1 and modulating insulin signaling (IS) through liver–muscle crosstalk. Mechanistically, ATG7 binds to IRS1, promoting its activation and the propagation of downstream IS. Notably, we identify an ATG7-derived peptide (Aap2) that recapitulates ATG7’s insulin-sensitizing effects and improves glycemic control in both Type 1 and Type 2 diabetic mouse models. These findings establish ATG7 as a key regulator of IS and suggest that targeting ATG7 may represent a promising therapeutic approach for IR and diabetes.

1 April 2021 in iScience
Verified
Journal Article
Open access
MWMitsuo Wada
Mitsuo Wada
KYKayo Yukawa
Kayo Yukawa
HOHiroyuki Ogasawara
Hiroyuki Ogasawara
KSKoichi Suzawa
Koichi Suzawa
TMTatsuya Maekawa
Tatsuya Maekawa
Takashi MikiTakashi Miki
Takashi Miki
Gpr52 is an orphan G-protein-coupled receptor of unknown physiological function. We found that Gpr52-deficient (Gpr52−/−) mice exhibit leanness associated with reduced liver weight, decreased hepatic de novo lipogenesis, and enhanced insulin sensitivity. Treatment of the hepatoma cell line HepG2 cells with c11, the synthetic GPR52 agonist, increased fatty acid biosynthesis, and GPR52 knockdown (KD) abolished the lipogenic action of c11. In addition, c11 induced the expressions of lipogenic enzymes (SCD1 and ELOVL6), whereas these inductions were attenuated by GPR52-KD. In contrast, cholesterol biosynthesis was not increased by c11, but its basal level was significantly suppressed by GPR52-KD. High-fat diet (HFD)-induced increase in hepatic expression of Pparg2 and its targets (Scd1 and Elovl6) was absent in Gpr52−/− mice with alleviated hepatosteatosis. Our present study showed that hepatic GPR52 promotes the biosynthesis of fatty acid and cholesterol in a ligand-dependent and a constitutive manner, respectively, and Gpr52 participates in HFD-induced fatty acid synthesis in liver.

1 November 2011 in Brain Research
Verified
Journal Article
Closed access
ELEun Young Lee
Eun Young Lee
SIShuji Inoue
Shuji Inoue
ASAkira Senoo
Akira Senoo
HSHiroyuki Shimizu
Hiroyuki Shimizu
YSYoko Suzuki
Yoko Suzuki
TMTakashi Miki
Takashi Miki